Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan W Jonker

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Journal of Lipid Research|July 21, 2019
Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in miceIvo P van de Peppel, Anna Bertolini, Theo H van Dijk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 6, 2020
Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal MaturationAndré A Weber, Elvira Mennillo, Xiaojing Yang, et al.
Handbook of Experimental Pharmacology|June 26, 2019
Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic DiseaseTim van Zutphen, Anna Bertolini, Hilde D de Vries, et al.
Pharmaceutical Research|April 23, 2005
Lack of improvement of oral absorption of ME3277 by prodrug formation is ascribed to the intestinal efflux mediated by breast cancer resistant protein (BCRP/ABCG2)Chihiro Kondo, Reiko Onuki, Hiroyuki Kusuhara, et al.
Scientific Reports|June 28, 2019
Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXRIrene Zwarts, Tim van Zutphen, Janine K Kruit, et al.
Cancer Research|October 16, 2003
The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridineAntonius E van Herwaarden, Johan W Jonker, Els Wagenaar, et al.
Nature Medicine|February 3, 2005
The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milkJohan W Jonker, Gracia Merino, Sandra Musters, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2013
Evidence for orphan nuclear receptor TR4 in the etiology of Cushing diseaseLi Du, Marvin Bergsneider, Leili Mirsadraei, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 23, 2020
Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in HepatocytesAli Saeed, Paulina Bartuzi, Janette Heegsma, et al.
Nature|December 16, 2011
Cryptochromes mediate rhythmic repression of the glucocorticoid receptorKatja A Lamia, Stephanie J Papp, Ruth T Yu, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Journal of Lipid Research|July 21, 2019
Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in miceIvo P van de Peppel, Anna Bertolini, Theo H van Dijk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 6, 2020
Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal MaturationAndré A Weber, Elvira Mennillo, Xiaojing Yang, et al.
Handbook of Experimental Pharmacology|June 26, 2019
Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic DiseaseTim van Zutphen, Anna Bertolini, Hilde D de Vries, et al.
Pharmaceutical Research|April 23, 2005
Lack of improvement of oral absorption of ME3277 by prodrug formation is ascribed to the intestinal efflux mediated by breast cancer resistant protein (BCRP/ABCG2)Chihiro Kondo, Reiko Onuki, Hiroyuki Kusuhara, et al.
Scientific Reports|June 28, 2019
Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXRIrene Zwarts, Tim van Zutphen, Janine K Kruit, et al.
Cancer Research|October 16, 2003
The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridineAntonius E van Herwaarden, Johan W Jonker, Els Wagenaar, et al.
Nature Medicine|February 3, 2005
The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milkJohan W Jonker, Gracia Merino, Sandra Musters, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2013
Evidence for orphan nuclear receptor TR4 in the etiology of Cushing diseaseLi Du, Marvin Bergsneider, Leili Mirsadraei, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 23, 2020
Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in HepatocytesAli Saeed, Paulina Bartuzi, Janette Heegsma, et al.
Nature|December 16, 2011
Cryptochromes mediate rhythmic repression of the glucocorticoid receptorKatja A Lamia, Stephanie J Papp, Ruth T Yu, et al.
Pageof 10